Stockholders’ Equity - Schedule of Options Activity (Details) - USD ($) $ / shares in Units, $ in Thousands	9 Months Ended	12 Months Ended
Sep. 30, 2026	Dec. 31, 2025
Number of Shares
Beginning balance (in shares)	7,534,665
Granted (in shares)	0
Exercised (in shares)	(1,785,162)
Forfeited (in shares)	(28,014)
Ending balance (in shares)	5,721,489	7,534,665
Number of Shares, Exercisable (in shares)	5,721,489
Weighted- Average Exercise Price
Beginning balance (in dollars per share)	$ 10.26
Granted (in dollars per share)	0
Exercised (in dollars per share)	4.18
Forfeited (in dollars per share)	18.22
Ending balance (in dollars per share)	12.11	$ 10.26
Weighted-Average Exercise Price, Exercisable (in dollars per share)	$ 12.11
Weighted- Average Remaining Contractual Life
Weighted- Average Remaining Contractual Life	2 years 9 months 3 days	6 years 3 months 10 days
Weighted-Average Remaining Contractual Life, Exercisable	2 years 9 months 3 days
Aggregate Intrinsic Value	$ 53,154	$ 102,102
Aggregate Intrinsic Value, Exercisable	$ 53,154

The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.

Name:	us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	instant

- Definition

The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.